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Neurotropic viruses initiate infection in peripheral tissues prior to entry into the central nervous system
(CNS). However, mechanisms of dissemination are not completely understood. We used genetically
marked viruses to compare dissemination of poliovirus, yellow fever virus 17D (YFV-17D), and reovirus
type 3 Dearing in mice from a hind limb intramuscular inoculation site to the sciatic nerve, spinal cord,
and brain. While YFV-17D likely entered the CNS via blood, poliovirus and reovirus likely entered the CNS
by transport through the sciatic nerve to the spinal cord. We found that dissemination was inefﬁcient in
adult immune-competent mice for all three viruses, particularly reovirus. Dissemination of all viruses
was more efﬁcient in immune-deﬁcient mice. Although poliovirus and reovirus both accessed the CNS by
transit through the sciatic nerve, stimulation of neuronal transport by muscle damage enhanced dis-
semination only of poliovirus. Our results suggest that these viruses access the CNS using different
pathways.
& 2015 Elsevier Inc. All rights reserved.Introduction
Neurotropic viruses can invade and infect the central nervous
system (CNS), which includes the spinal cord and brain. These
viruses come from a variety of different families and include sev-
eral that infect humans (Koyuncu et al., 2013). Neurotropic viruses
enter the CNS through peripheral nerves or by crossing the blood–
brain barrier following hematogenous dissemination. Different
viruses target different cell types within the nervous system,
causing symptoms ranging from seizures to paralysis or death.
Here, we investigated the dissemination patterns of three neuro-
tropic viruses, each from a different family, to discern whether
common mechanisms are employed to invade the CNS. Viral dis-
semination barriers can be masked by titer-based assays since
post-barrier viral replication can produce high viral titers (Erick-
son and Pfeiffer, 2013; Kuss et al., 2008; Lancaster and Pfeiffer,
2010; Pfeiffer and Kirkegaard, 2006). Therefore, we used geneti-
cally marked virus pools to examine dissemination of poliovirus,
yellow fever virus 17D (YFV-17D), and reovirus.(J.K. Pfeiffer).Poliovirus is a nonenveloped virus with a positive-sense,
single-stranded RNA genome from the Picornaviridae family. It is
most commonly transmitted in humans by the fecal-oral route and
causes paralysis in less than 1% of infected individuals due to
damage to motor neurons. Poliovirus accesses the CNS by either
crossing the blood–brain barrier (Yang et al., 1997) or via retro-
grade axonal transport in peripheral nerves (Ohka et al., 1998;
Pfeiffer, 2010; Ren and Racaniello, 1992). Young mice and immune-
deﬁcient mice engineered to express the poliovirus receptor (PVR/
CD155) have enhanced susceptibly to poliovirus infection (Crotty
et al., 2002; Ida-Hosonuma et al., 2005; Ohka et al., 2007). When
poliovirus is inoculated into the hind limb muscle of these mice,
the virus spreads to the CNS by transport through the sciatic nerve
to the spinal cord and brain. Concordantly, sciatic nerve transec-
tion limits poliovirus spread to the CNS following intramuscular
inoculation (Gromeier and Wimmer, 1998; Ohka et al., 1998; Ren
and Racaniello, 1992). Poliovirus enters neurons and other cell
types by binding PVR, followed by endocytosis and uncoating
(Koike et al., 1991b; Ohka et al., 2007; Ren and Racaniello, 1992).
The cytoplasmic domain of PVR interacts with Tctex-1, a light
chain of cytoplasmic dynein, which facilitates transport of virus-
containing endosomes through the fast retrograde transport sys-
tem (Mueller et al., 2002; Ohka et al., 2004). It is unclear whether
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poliovirus in neurons.
YFV is an enveloped virus with a positive-sense, single-
stranded RNA genome from the Flaviviridae family. YFV usually
infects humans through the bite of a mosquito, with outcomes
ranging from asymptomatic infection to severe hemorrhagic fever.
YFV rarely enters the CNS, but the virus is capable of causing
encephalitis (Monath and Barrett, 2003). The receptor for YFV and
its mechanism of entry into the CNS are not known. YFV strain 17D
(YFV-17D) is a live-attenuated vaccine strain derived from the
virulent Asibi strain. It is one of the safest live-attenuated vaccines
available, but in rare cases, YFV-17D can enter the CNS and induce
encephalitis following vaccination (Monath and Barrett, 2003).
Laboratory rodents have varying degrees of susceptibility to YFV-
17D, with young and immune-deﬁcient animals having the
greatest susceptibility (Fitzgeorge and Bradish, 1980; Lee and
Lobigs, 2008; Meier et al., 2009; Theiler, 1930; Thibodeaux et al.,
2012). Early studies suggested that YFV disseminates to the CNS
hematogenously (Mims, 1957; Sawyer and Lloyd, 1931); indeed,
many ﬂaviviruses access the CNS through blood. It is unclear
whether YFV can undergo retrograde transport in neurons.
Mammalian orthoreoviruses (hereafter called reoviruses) are
nonenveloped viruses with a segmented double-stranded RNA
genome from the Reoviridae family. Reovirus infects humans by
the fecal-oral route, but individual strains differ in their dis-
semination patterns and receptor speciﬁcities (Barton et al., 2003;
Weiner et al., 1977; Weiner et al., 1980). Reovirus infects most
humans during childhood and, in rare instances, reovirus is cap-
able of entering the CNS in humans. The age-dependent barrier to
reovirus CNS entry is recapitulated in mice, as reovirus dis-
seminates to the brain of young but not adult mice following
intramuscular inoculation (Mann et al., 2002; Tardieu et al., 1983).
In mice, strain type 1 Lang (T1L) disseminates to the CNS primarily
through a hematogenous route, while strain type 3 Dearing (T3D)
disseminates to the CNS through neural or hematogenous path-
ways (Antar et al., 2009; Boehme et al., 2011; Morrison et al., 1991;
Tyler et al., 1986). When reovirus T3D is inoculated into the hind
limb muscle of newborn mice, the virus spreads to the CNS by
trafﬁcking through the sciatic nerve to the spinal cord. Sciatic
nerve transection inhibits T3D dissemination from the hind limb
muscle to the spinal cord (Boehme et al., 2011; Tyler et al., 1986).
However, sciatic nerve transection delays, but does not prevent,
T3D spread to the brain following intramuscular inoculation,
highlighting the importance of hematogenous spread following
this inoculation route (Boehme et al., 2011). T1L and T3D reo-
viruses attach to host cells using cell-surface glycans and junc-
tional adhesion molecule A, followed by receptor-mediated
endocytosis (Barton et al., 2001a; Barton et al., 2001b; Campbell
et al., 2005; Forrest et al., 2003; Maginnis et al., 2006; Reiss et al.,
2012). T3D infects neurons using the Nogo receptor NgR1,
although glycan interactions are also important for viral attach-
ment to neurons (Frierson et al., 2012; Konopka-Anstadt et al.,
2014). NgR1 is a GPI-anchored protein that is unlikely to interact
directly with dynein (Saha et al., 2014). However, dynein is
required for reovirus entry and endocytic transport in non-
neuronal cells (Mainou et al., 2013). An inhibitor of fast retro-
grade axonal transport inhibits T3D dissemination to the CNS in
mice (Tyler et al., 1986), suggesting that dynein-mediated fast
retrograde axonal transport is involved in reovirus transport in
neurons.
The mouse sciatic nerve is a tractable model system to study
how viruses move from the periphery to the CNS because of its
length, width, and ease of dissection. Following intramuscular
inoculation of the hind limb, viruses can enter the sciatic nerve and
transit by retrograde fast axonal transport using dynein motors
(Ohka et al., 1998; Ren and Racaniello, 1992; Tyler et al., 1986). Thistransport system is essential, considering that viruses travel long
distances within an axon. For example, viruses inoculated into the
gastrocnemius muscle of the adult mouse travel over 2 cm within a
single cell prior to reaching the site of viral replication in the cell
body. The sciatic nerve model has been used to examine the routes
by which neurotropic viruses gain access to the CNS and to study
the effects of the type I interferon (IFN) response and stimulation of
retrograde axonal transport (Boehme et al., 2011; Gromeier and
Wimmer, 1998; Ida-Hosonuma et al., 2005; Koyuncu et al., 2013;
Lancaster and Pfeiffer, 2010; Mann et al., 2002; Tyler et al., 1986).
For example, poliovirus transport in the sciatic nerve of mice is
inefﬁcient, but efﬁciency is enhanced by ablating the type I IFN
response or increasing retrograde axonal transport via muscle
damage. Importantly, virulence correlates with viral diversity in the
CNS: mice with high viral diversity in the CNS have higher mortality
than mice with low viral diversity in the CNS (Kuss et al., 2008;
Lancaster and Pfeiffer, 2010; Pfeiffer and Kirkegaard, 2005; Vignuzzi
et al., 2006).
Although the mechanism is unclear, damage to muscle
increases transport of both poliovirus and non-viral cargo protein
in the sciatic nerve (Gromeier and Wimmer, 1998; Lancaster and
Pfeiffer, 2010). Muscle damage also decreases the time to disease
onset in poliovirus-infected mice (Gromeier and Wimmer, 1998;
Lancaster and Pfeiffer, 2010). This damage response and sub-
sequent enhanced poliovirus transport in neurons also may be
operative in humans. In children, injury to muscle from trauma or
intramuscular injections increases the incidence of poliovirus-
induced paralysis, particularly in the damaged limb (Anderson
and Skaar, 1951; Guyer et al., 1980; Hill and Knowelden, 1950;
McCloskey and Melb, 1950; Strebel et al., 1995; Wyatt, 1985). The
effect of muscle damage on transport of other viruses is unclear.
To investigate differences in dissemination patterns of distinct
neurotropic viruses, we intramuscularly inoculated adult or new-
born immune-competent or immune-deﬁcient mice lacking the
type I IFN-α/β receptor (IFNAR/) with genetically marked
pools of poliovirus, YFV-17D, or reovirus T3D. We quantiﬁed viral
dissemination at 72 h post-inoculation (hpi) and found that dis-
semination of reovirus T3D was more restricted than poliovirus
and YFV-17D in adult immune-competent mice. All three viruses
had enhanced dissemination in IFNAR/ mice. Stimulating ret-
rograde axonal transport with muscle damage enhanced polio-
virus dissemination but did not enhance dissemination of either
YFV-17D or reovirus T3D. Dissemination of poliovirus and reovirus
was substantially enhanced in newborn mice, with reovirus
showing the largest differences as a function of host age. Overall,
our results suggest that poliovirus, YFV-17D, and reovirus T3D
disseminate to the CNS using different pathways with different
efﬁciencies.Results
Immune deﬁciency, muscle damage, and young age enhance polio-
virus transport to the CNS
Analysis of viral titer is not always sufﬁcient to deﬁne viral
dissemination barriers; in fact, robust viral replication following
traverse of a barrier can mask barriers completely (Kuss et al.,
2008; Lancaster and Pfeiffer, 2010; Pfeiffer and Kirkegaard, 2006).
To overcome this obstacle, we inoculated mice with genetically
marked viruses and used a hybridization-based assay to quantify
the viral population diversity in a given tissue (Kuss et al., 2008;
Lancaster and Pfeiffer, 2010). A decrease in viral population
diversity from one tissue to another indicates a viral transport
barrier. Using this approach, we previously found that poliovirus
transport to the CNS is inefﬁcient, but ablating the type I IFN
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found that muscle damage increased poliovirus transport to the
CNS by enhancing retrograde axonal transport in the sciatic nerve
(Lancaster and Pfeiffer, 2010). However, our previous study ana-
lyzed viral titer and population diversity in tissues at disease
onset, days 3–8 post-inoculation. Here, we examined viral trans-
port to the CNS at an early time point, 72 hpi, to determine
whether the type I IFN response, muscle damage, or host age
inﬂuences viral dissemination early in infection.
To examine viral transport early in infection, IFNARþ/þ or
IFNAR/ mice were inoculated intramuscularly with 10Fig. 1. Experimental design. Mice were inoculated intramuscularly (IM) with 107 PFU o
were collected at 72 hpi unless otherwise indicated. Muscle damage was induced in a sub
transport in the sciatic nerve.
Fig. 2. Dissemination of poliovirus to the CNS is limited by inefﬁcient retrograde axonal t
inoculated intramuscularly with 107 PFU total of 10 genetically marked polioviruses, w
determined by plaque assay, and viral population diversity was determined using a hyb
diversity (B) in tissues harvested from adult IFNARþ/þ or IFNAR/ mice with or
Poliovirus titer (C) and viral population diversity (D) in tissues harvested from 3-day-old
to the onset of disease. Results are presented as mean þ/ standard error of the mean fr
the Mann–Whitney test, are indicated by asterisks as follows: *Po0.05, **Po0.005, ***genetically marked polioviruses (Fig. 1). Tissues were harvested at
72 hpi, and viral titer and population diversity were quantiﬁed.
Similar to previous studies at late time points (Kuss et al., 2008;
Lancaster and Pfeiffer, 2010), we found increased viral titers in all
tissues of IFNAR/ mice relative to IFNARþ/þ mice (Fig. 2A,
white vs. gray bars). Similarly, viral population diversity was
greater in IFNAR/ mice relative to IFNARþ/þ mice, and viral
population diversity was less in brain compared with muscle
(Fig. 2B, white vs. gray bars). In contrast to previous studies at later
time points where viral brain titers were high (Lancaster and
Pfeiffer, 2010), viral titers in the brain were very low at 72 hpi inf 10 poliovirus (PV), six YFV-17D, or nine reovirus (RV) pool members, and tissues
set of mice before, during, and after viral inoculation to stimulate retrograde axonal
ransport, type I IFN responses, and older age. IFNARþ/þ and IFNAR/ mice were
ith or without additional muscle damage. Tissues were collected, viral titers were
ridization-based assay (Kuss et al., 2008). Poliovirus titer (A) and viral population
without muscle damage. Tissues were collected at 72 hpi, prior to disease onset.
IFNARþ/þ or IFNAR/ mice. Tissues were collected at 48 hpi in (C) and (D) due
om 4–8 mice per condition. Values that are signiﬁcantly different, as determined by
Po0.0005. Mus., muscle; ND, none detected.
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brain were 48000-fold higher in IFNAR/ mice compared to
IFNARþ/þ mice. Overall, these data suggest that poliovirus
transport to the CNS is inefﬁcient, particularly in adult immune-
competent mice, at 72 hpi.
We next examined the effect of muscle damage on poliovirus
transport to the CNS at 72 hpi. Muscle damage was induced daily
starting 1 d before viral inoculation and concluding 1 d prior to
tissue collection (Fig. 1). Titers of poliovirus in tissues were gen-
erally higher in IFNARþ/þ mice with damage compared with
those in IFNARþ/þ mice without damage (Fig. 2A, white vs. white
hatched bars). In fact, mean poliovirus titers in brain were
4270,000-fold higher in mice with muscle damage compared
with mice lacking muscle damage. The muscle and brain tissues of
IFNAR/ mice with muscle damage also show increased titer
compared with IFNAR/ mice without damage (Fig. 2A, gray vs.
gray hatched bars). Not surprisingly, viral population diversity was
also higher for mice with muscle damage (Fig. 2B). Strikingly, the
effect of muscle damage on viral titer and viral population diver-
sity in the brain was greater than ablation of the type I IFN
response. Although poliovirus replicated more efﬁciently in
IFNAR/ mice, trafﬁcking to the CNS was still restricted by a
barrier that was overcome by muscle damage. These results sug-
gest that early in infection inefﬁcient retrograde axonal transport
and type I IFN restrict poliovirus trafﬁcking to the CNS by different
mechanisms. Furthermore, inefﬁcient retrograde axonal transport
is a stronger barrier for poliovirus dissemination to the CNS than
the type I IFN response.
To determine whether barriers to poliovirus CNS dissemination
exist in very young mice, we inoculated 3-day-old IFNARþ/þ or
IFNAR/ mice with the pool of genetically marked viruses andFig. 3. Dissemination of YFV-17D to the CNS is limited by type I IFN responses but n
inoculated intramuscularly with 107 PFU total of six genetically marked YFV-17D virus
collected at 72 hpi, prior to disease onset. Viral titers were determined by plaque assay
YFV-17D titer (A) and viral population diversity (B) in tissues harvested from adult IFNA
viral population diversity (D) in tissues harvested from 3-day-old IFNARþ/þ or IFNAR/
the mean from 6–8 mice per condition. Values that are signiﬁcantly different, as deter
**Po0.005, ***Po0.0005. Mus., Muscle; ND, none detected.assessed viral titers and population diversity. Infected mice were
moribund at 48 hpi; therefore, tissues were collected at this earlier
time point. Viral titers were very high in muscle, spinal cord, and
brain in both IFNARþ/þ and IFNAR/ mice, and all pool
members were present in all tissues (Fig. 2C and D). In agreement
with previous studies, these data suggest that a major barrier
limiting viral dissemination develops as mice age (Crotty et al.,
2002). Overall, poliovirus dissemination is limited most by age-
speciﬁc factors, followed by inefﬁcient retrograde axonal trans-
port, and the type I IFN response. Importantly, young mice may
have altered IFN responses and retrograde axonal transport com-
pared with adult mice, which may contribute to the enhanced
dissemination of poliovirus in these animals.
Immune deﬁciency, but not muscle damage, enhances YFV-17D
transport to the CNS
Using a pool of six genetically marked viruses, we previously
found that YFV-17D inoculated intramuscularly disseminated to the
brain relatively efﬁciently in IFNAR/ mice at 7–8 dpi (Erickson
and Pfeiffer, 2013). Here, we examined YFV-17D dissemination at
72 hpi to better understand the kinetics of viral transport by eval-
uating the effect of immune deﬁciency, muscle damage, and host
age on viral dissemination. We found that immune-competent
adult IFNARþ/þ mice had moderate titers of YFV-17D in all tis-
sues tested (Fig. 3A, white bars). While immune-deﬁcient IFNAR/
 mice had higher YFV-17D titers in several tissues, surprisingly,
viral titers in brain were only 1.3-fold higher than those in IFNARþ/
þ mice (Fig. 3A, white vs. gray bars). For most tissues, viral popu-
lation diversity was greater in IFNAR/ mice compared with that
in IFNARþ/þ mice (Fig. 3B, white vs. gray bars). Although viralot inefﬁcient retrograde axonal transport. IFNARþ/þ and IFNAR / mice were
es, with or without additional muscle damage for IFNARþ/þ mice. Tissues were
, and viral population diversity was determined using a hybridization-based assay.
Rþ/þ or IFNAR / mice with or without muscle damage. YFV-17D titer (C) and
 mice infected with 104 PFU. Results are presented as mean þ/ standard error of
mined by the Mann–Whitney test, are indicated by asterisks as follows: *Po0.05,
Fig. 4. Poliovirus and YFV-17D likely reach the brain through different routes. Viral
pool members detected in the brain were scored relative to the pool members
detected in the sciatic nerve, spinal cord, or blood of each IFNARþ/þ or IFNAR/
mouse to determine the degree of overlap. We used only mice in which less than or
equal to half of the total pool members were detected in the brain, since animals
with most or all of the pool members present in the brain would be uninformative
for determining trafﬁcking routes. Each symbol represents a single mouse. Bars
represent means of 3–18 mice. Data are shown as percent match of viral pool
members present in the brain to viral pool members present in each tissue. As an
example, if the brain contained poliovirus pool members 2 and 4 (of 10 total) and
the spinal cord contained poliovirus pool members 4, 6, 8, and 10, then the percent
match of brain viruses to viral pool members present in the spinal cord is 50% ([1
matching virus/2 total viruses present in brain]  100). Values that are sig-
niﬁcantly different, as determined by the Mann–Whitney test, are indicated by
asterisks as follows: *Po0.05, **Po0.005, ***Po0.0005.
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viral population diversity was greater in IFNAR/ mice. These
results suggest that YFV-17D may encounter a barrier in IFNARþ/þ
mice en route to the brain that was overcome in IFNAR/ mice or
that clearance of the virus differs in the two mouse strains.
Because YFV and YFV-17D are thought to enter the CNS pre-
dominantly via the hematogenous route (Mims, 1957; Sawyer and
Lloyd, 1931), and muscle damage stimulates transport in neurons,
we hypothesized that muscle damage would not alter YFV-17D
dissemination to the brain. Indeed, viral titers were not higher in
IFNARþ/þ mouse tissues at 72 hpi following muscle damage
(Fig. 3A, white vs. hatched bars). In fact, viral titers were lower in
mice with muscle damage, suggesting that muscle injury reduced
viral replication and dissemination. Muscle damage was associated
with increased YFV-17D population diversity in muscle tissue but
not in any of the peripheral or central nervous system tissues
tested (Fig. 3B, white vs. hatched bars). It is possible that inﬂam-
mation associated with muscle damage reduced YFV-17D
replication.
To determine whether YFV-17D disseminates more efﬁciently
in very young mice, we inoculated 3-day-old IFNARþ/þ or
IFNAR/ mice with the pool of genetically marked viruses and
assessed viral titers and population diversity in tissues harvested
at 72 hpi. Due to the small inoculation volume required for infant
mice and low YFV-17D concentration, mice were inoculated with
104 PFU in these experiments rather than the 107 PFU inoculum
used in experiments with adult animals. Therefore, direct com-
parisons between YFV-17D dissemination in adult vs. young mice
could not be made. However, we were able to evaluate the relative
viral dissemination efﬁciencies in IFNARþ/þ and IFNAR/
infant mice. Not surprisingly, YFV-17D titers were higher and
population diversity was greater in IFNAR/ mice compared
with those parameters in IFNARþ/þ mice (Fig. 3C and D). Strik-
ingly, YFV-17D titers were undetectable in the brain of immune-
competent young mice, while immune-deﬁcient mice contained
4104 PFU in the brain. Therefore, the type I IFN response is a
major barrier in young mice to dissemination of YFV-17D. Tracing
individual viral pool members reveals different transport routes of
poliovirus and YFV-17D to the CNS
A major strength of using genetically marked viruses for viral
dissemination studies is that they can be used to determine viral
transport routes from the periphery to the CNS. To determine
whether intramuscularly inoculated YFV-17D disseminated to the
brain through the blood rather than through peripheral nerves, we
compared speciﬁc pool members found in tissues of adult mice.
YFV-17D pool members detected in the brain were scored relative
to the pool members detected in the sciatic nerve, spinal cord, or
blood of each mouse to determine the degree of overlap. For this
analysis, we used only mice in which less than or equal to half of
the total pool members were detected in the brain, since animals
with most or all of the pool members present in the brain would
be uninformative for determining trafﬁcking routes. We found
that, on average, a YFV-17D pool member detected in the brain
was detected in the sciatic nerve in 45% of mice, in the spinal cord
in 10% of mice, and in the blood in 75% of mice (Fig. 4). Therefore,
viruses found in the brain matched viruses found in the blood to a
greater extent than viruses found in the sciatic nerve or spinal
cord. In contrast, poliovirus pool members detected in the brain
matched the pool members detected in the sciatic nerve and
spinal cord in 98–100% of cases, and poliovirus was undetectable
in the blood (Fig. 4). These data are consistent with previous
studies showing that poliovirus disseminates through nerves to
reach the mouse brain (Ohka et al., 2004; Ohka et al., 1998; Ren
and Racaniello, 1992) and support the idea that YFV-17D dis-
seminates primarily through the blood to infect the CNS (Mims,
1957; Sawyer and Lloyd, 1931).Development of a reovirus T3D population diversity assay
To examine reovirus dissemination in mice, we engineered a
panel of nine genetically marked reovirus strains that can be dis-
tinguished using a hybridization-based population diversity assay.
The strains each contain a combination of unique silent mutations
in the M1 gene segment such that RT-PCR products of each pool
member are recognized by speciﬁc oligonucleotide probes
(Fig. 5A). The speciﬁcity of each probe was conﬁrmed by blotting
RT-PCR products from individual strains on membranes, followed
by hybridization with each 32P-labeled oligonucleotide probe
(Fig. 5B). To determine whether any of the strains have altered
replication efﬁciency compared with the others, we performed an
in vitro viral serial passage experiment. This type of analysis is
more sensitive than single-cycle replication assays for detection of
subtle replication differences (Kuss et al., 2008). After an initial
infection with a mixture containing equal aliquots of each pool
member, we used the infected cells to initiate viral replication in
naïve cells, and relative levels of each pool member were quanti-
ﬁed over seven serial passages. In this experiment, all pool
members were present at similar levels in the initial and ﬁnal
passages (Fig. 5C), suggesting that the pool members have similar
ﬁtness in vitro. To determine whether the genetically marked
reovirus strains differ in ﬁtness in vivo, we inoculated mice
intramuscularly with a mixture of all nine pool members and
examined viral population diversity at 72 hpi. A blot of the reo-
virus pool members in peripheral and CNS tissues of a repre-
sentative IFNAR/ mouse is shown in Fig. 5D. To conﬁrm that
reovirus pool members have equivalent ﬁtness in vivo, viral
population diversity data for all reovirus mouse experiments
were compiled to determine the relative number of times
each pool member was detected. All nine reovirus pool members
were detected with similar frequency (Fig. 5E), providing
strong evidence that the pool members have comparable ﬁtness
in vivo.
Fig. 5. Development of a hybridization-based reovirus T3D viral population diversity assay. (A) Sequence alignment showing groups of silent point mutations introduced
into the reovirus T3D M1 gene segment. The amino acid sequence is shown at the top. (B) Blots demonstrating speciﬁcity of each probe for its cognate viral RT-PCR product.
(C) Serial passage competition experiment showing maintenance of all pool members. L929 cells were adsorbed with equivalent PFU of each reovirus pool member. Infected
cells were collected at 24 hpi and used to initiate another cycle of replication in naïve cells. Following seven passages, the ratios of viruses were compared by hybridization
assay. (D) Representative blot of RT-PCR products from a reovirus-infected IFNAR / mouse following intramuscular inoculation. Mice were inoculated intramuscularly
with 107 PFU total of the nine genetically marked reoviruses. Tissues were collected at 72 hpi, and viral population diversity was assessed using the hybridization assay.
(E) Relative prevalence of each reovirus pool member in all mouse tissues collected during this study. Data were derived from tissues of 63 mice. The relatively equal
prevalence of each pool member indicates that pool members do not have signiﬁcant ﬁtness differences in vivo.
Fig. 6. Dissemination of reovirus T3D to the CNS is limited by type I IFN responses and older age but not inefﬁcient retrograde axonal transport. IFNARþ/þ and IFNAR/
mice were inoculated intramuscularly with 107 PFU total of nine genetically marked reoviruses, with or without additional muscle damage. Viral titers were determined by
plaque assay, and viral population diversity was determined using a hybridization-based assay. Reovirus T3D titer (A) and viral population diversity (B) in tissues harvested
from adult IFNARþ/þ or IFNAR / mice with or without muscle damage. Tissues were collected at 72 hpi. (C) Reovirus T3D titer in tissues from adult mice collected at 7 d
post-inoculation. Reovirus T3D titer (D) and viral population diversity (E) in tissues from 3-day-old IFNARþ/þ or IFNAR/ mice. Tissues were collected at 72 hpi, prior to
disease onset. Results are presented as mean þ/ standard error of the mean from 5–9 mice per condition. Values that are signiﬁcantly different, as determined by the
Mann–Whitney test, are indicated by asterisks as follows: *Po0.05, **Po0.005, ***Po0.0005. Mus., Muscle, SN, Sciatic Nerve, SC, Spinal Cord, Br., Brain. ND, none detected.
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Fig. 7. Co-infection with poliovirus does not enhance reovirus dissemination to the
CNS. IFNARþ/þ and IFNAR/ mice were inoculated intramuscularly with
107 PFU total of nine genetically marked reoviruses and 107 PFU total of 10
genetically marked polioviruses. Tissues were collected at 72 hpi. Reovirus titers
and population diversity were determined by plaque assay and hybridization-based
assay, respectively, using L929 cells, which do not support poliovirus replication.
Reovirus T3D titer (A) and viral population diversity (B) in tissues harvested from
adult IFNARþ/þ or IFNAR/ mice with or without muscle damage. ‘ind’ indi-
cates data from infections with reovirus only (from Fig. 6A, B data), and ‘co’ indi-
cates data from the reovirus–poliovirus co-infection. Results are presented as mean
þ/ standard error of the mean from 5–7 mice per condition. Values that are
signiﬁcantly different, as determined by the Mann–Whitney test, are indicated by
asterisks as follows: *Po0.05. ND, none detected.
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reovirus T3D transport to the CNS
To deﬁne factors that inﬂuence reovirus dissemination from the
periphery to the CNS in mice, we examined trafﬁcking of the nine
genetically marked reoviruses following intramuscular inocula-
tion. In accordance with previous work (Dionne et al., 2011), viral
titers in muscle, sciatic nerve, and spinal cord were signiﬁcantly
higher in adult IFNAR/ mice than those in adult IFNARþ/þ
mice (Fig. 6A, white vs. gray bars). Remarkably, reovirus dis-
semination to the upper sciatic nerve and spinal cord was
observed only in IFNAR/ mice (Fig. 6A). Viral population
diversity was modest in IFNARþ/þ tissues and greater in
IFNAR/ tissues (Fig. 6B, white vs. gray bars). Reovirus was not
detected in the brain of adult mice of either strain at 72 hpi, which
was not surprising given the well-established restriction of reo-
virus dissemination to the CNS in adult mice (Mann et al., 2002;
Tardieu et al., 1983).
Because reovirus T3D and poliovirus both infect neurons and
are transported by fast retrograde axonal transport, we hypothe-
sized that muscle damage would enhance reovirus transport as
observed in the case of poliovirus transport. Although damage
induced small increases in reovirus titers in muscle of both
IFNARþ/þ and IFNAR/ mice, muscle injury was not sufﬁcient
to enhance reovirus dissemination to the sciatic nerve, spinal cord,
or brain in IFNARþ/þ mice (Fig. 6A, white vs. white hatched bars).
Muscle damage was associated with increased viral population
diversity in muscle of IFNARþ/þ mice but generally not in other
tissues (Fig. 6B). In IFNAR/ mice, increases in viral population
diversity following muscle damage were only signiﬁcant in the
upper sciatic nerve (Fig. 6B). Overall, these experiments show that
dissemination of intramuscularly inoculated reovirus is severely
restricted in immune-competent adult mice and that muscle
damage does not enhance viral dissemination from the
inoculation site.
We next determined whether a longer infectious time course
would allow increased reovirus dissemination to the CNS. Reovirus
replicates more slowly than poliovirus and may require a longer
interval to reach the brain. Therefore, we compared viral titers in
adult IFNARþ/þ and IFNAR/ mice with and without muscle
damage at 7 d post-inoculation. In most tissues tested, viral
titers were lower at 7 days post-inoculation than at 72 hpi
(Fig. 6C vs. Fig. 6A). Reovirus was not detected in the brain of adult
mice under any of the conditions tested (Fig. 6C). Therefore, the
lack of reovirus dissemination to the brain of adult mice at 72 hpi
is not simply due to the relatively early time point of tissue
collection.
To determine whether reovirus T3D disseminates more efﬁ-
ciently in very young mice, we inoculated 3-day-old IFNARþ/þ or
IFNAR/ mice with the pool of genetically marked viruses and
assessed viral titers and population diversity. Reovirus titers were
detectable in all tissues of young mice, including brain, with sig-
niﬁcantly higher titers in IFNAR/ mice compared with those in
INFARþ/þ mice (Fig. 6D). Notably, all reovirus pool members
were detected in the brains of INFAR/ mice (Fig. 6E). However,
only about 25% of pool members were detected in the brains of
IFNARþ/þ mice, revealing an IFN-mediated barrier limiting reo-
virus infection of the brain in young mice. Collectively, these
experiments are consistent with previous ﬁndings on age-
dependent and IFN-dependent barriers to reovirus dissemination
(Dionne et al., 2011; Mann et al., 2002; Sherry et al., 1998; Tardieu
et al., 1983).Co-infection with poliovirus does not enhance reovirus dissemination
to the CNS
Since poliovirus is more efﬁciently transported than reovirus in
neurons of IFNARþ/þ and IFNAR/ mice, we were curious
about whether co-infection with poliovirus could enhance reo-
virus transport. We thought it possible that poliovirus infection
might stimulate host pathways that mediate viral transport in
neurons, which in turn would enhance transport of other types of
cargoes. To test this hypothesis, adult mice were inoculated
intramuscularly with 107 PFU of the 10 genetically marked polio-
viruses and 107 PFU of the nine genetically marked reoviruses for a
total inoculum of 2107 PFU. Tissues were resected at 72 hpi and
processed for virus titer determination and population diversity
assay using L929 cells, which do not support poliovirus replication.
When titer and diversity data from co-infected mice (‘co’) are
compared with data from individually infected mice (‘ind’, from
Fig. 6A and B), we found no detectable change (enhancement or
diminishment) in reovirus transport following co-infection with
poliovirus (Fig. 7A and B). This ﬁnding suggests that poliovirus and
reovirus disseminate to the CNS using distinct pathways.Discussion
Knowledge about how different viruses disseminate to the CNS
is essential for a comprehensive understanding of the
Table 1
Comparing CNS dissemination of three distinct neurotropic viruses.
Reovirus T3D Poliovirus YFV-17D
Viral titer in brain of
adult IFNARþ/þ
mice
Undetectable Very low Moderate
Probable dissemina-
tion route to brain
Peripheral
neurons
Peripheral
neurons
Blood
Primary barrier Age Age Interferon
Secondary barrier Interferon Inefﬁcient retro-
grade axonal
transport
Age
Tertiary barrier – Interferon –
Effect of muscle
damage
 No effect ↑ Dissemination ↓ Dissemination
Effect of IFNAR/ ↑ Dissemination ↑ Dissemination ↑ Dissemination
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compared the transport of three different neurotropic viruses
following intramuscular inoculation of mice using viral titer and
population diversity assays. We found that poliovirus, YFV-17D,
and reovirus T3D disseminate to the CNS with varying efﬁciencies
and use distinct mechanisms that are affected differently by host
damage responses (Table 1).
Although injury to the muscle at the inoculation site enhanced
neuronal transport of poliovirus in both IFNARþ/þ and IFNAR/
 mice, muscle damage did not enhance transport of either YFV-
17D or reovirus T3D. In fact, muscle damage reduced YFV-17D
dissemination. YFV-17D likely enters the brain by crossing the
blood–brain barrier following hematogenous dissemination rather
than by transport through peripheral nerves into the spinal cord.
Therefore, enhancement of retrograde axonal transport in neurons
induced by muscle damage would be less likely to increase YFV-
17D dissemination to the CNS. Interestingly, blood–brain barrier
disruption by needle puncture enhances dissemination of per-
ipherally inoculated YFV to the brain, but peripheral tissue damage
does not (Mims, 1957; Sawyer and Lloyd, 1931). Poliovirus and
reovirus share many biological properties such as fecal-oral
transmission, dissemination in peripheral nerves, dependence on
dynein for transport, and spread in neurons by fast retrograde
axonal transport. Therefore, it was somewhat surprising that
muscle damage enhanced neuronal transport of poliovirus but not
reovirus. Damage-dependent enhancement of retrograde axonal
transport occurs for wheat germ agglutinin (Lancaster and Pfeiffer,
2010), indicating that accelerated transport as a consequence of
muscle injury can occur with cargoes other than viruses. Collec-
tively, these observations provide additional evidence that polio-
virus and reovirus trafﬁc in the nervous system using different
mechanisms.
Injury to muscle at the inoculation site enhanced YFV-17D and
reovirus population diversity in the muscle of IFNARþ/þ mice as
well as reovirus titer in the muscle of IFNARþ/þ and IFNAR/
animals. However, increased viral titer and population diversity in
muscle as a consequence of damage did not enhance transport
through peripheral nerves for either virus, suggesting that the
effect may be due to muscle-speciﬁc factors that enhance viral
replication or decrease viral clearance.
Co-infection with poliovirus did not accelerate neuronal
transport of reovirus, likely due to differences in the host transport
mechanisms used by these viruses. We think it possible that each
virus associates with different neuronal compartments during
transport. Differences in receptor utilization also may control
transport efﬁciency. The PVR cytoplasmic domain associates with
dynein light chain Tctex-1 to transport poliovirus using dynein
motors (Mueller et al., 2002; Ohka et al., 2004). Reovirus T3D
requires NgR1 to infect neurons, but NgR1 is GPI-anchored andtherefore not likely to associate directly with any dynein compo-
nents outside of reovirus-containing endosomes (Konopka-
Anstadt et al., 2014; Saha et al., 2014). NgR1 is expressed at high
levels in the adult brain but, because of myelination in the adult,
the receptor may not be available for reovirus T3D binding and
entry (Konopka-Anstadt et al., 2014). This aspect of NgR1 phy-
siology could explain the age-speciﬁc barrier to reovirus infection.
In contrast, PVR is widely expressed and available for poliovirus
binding and entry into the brain.
Findings made in this study show that poliovirus, YFV-17D, and
reovirus T3D disseminate to the CNS by distinct mechanisms. By
using assays of viral load and viral population diversity, we
uncovered dissemination routes to the CNS and identiﬁed barriers
to dissemination for each of these viruses. Enhancement of fast
retrograde axonal transport by muscle damage increased dis-
semination of poliovirus but not YFV-17D or reovirus T3D. These
ﬁndings highlight the complexity of neurotropic virus access to the
CNS and provide a framework to deﬁne virus-speciﬁc neural
transportation routes.Materials and methods
Plasmid construction
The plasmids used to prepare the nine genetically marked
reovirus strains were engineered using site-directed mutagenesis
of the M1 gene segment of the reovirus T3D M1 cDNA plasmid
beginning with nucleotide 426 and ending at nucleotide 444 (see
Fig. 4A). PCR products were subcloned using Bgl II and Mfe I
restriction sites. Fidelity of mutagenesis for each PCR-generated
region was conﬁrmed by sequencing (Sequencing Core, UT
Southwestern Medical Center, Dallas, TX). The 10 poliovirus plas-
mids and six YFV-17D plasmids have been described (Erickson and
Pfeiffer, 2013; Kuss et al., 2008; Pfeiffer and Kirkegaard, 2003).
Viruses and cells
L929 cells (reovirus) and BHK cells (YFV-17D) were propagated
in Dulbecco's modiﬁed Eagle's medium (DMEM) with 5% fetal
bovine serum, and HeLa cells (poliovirus) were propagated in
DMEM with 10% calf serum. Reovirus plaque assays were per-
formed as described using 6105 L929 cells seeded into wells of
6-well plates. Monolayers were stained with neutral red at 6 d
post-infection, and plaques were counted at 7 d post-infection
(Virgin et al., 1988). Poliovirus plaque assays were performed as
described using 106 HeLa cells seeded into wells of 6-well plates.
Monolayers were stained with crystal violet at 2 d post-infection
(Pfeiffer and Kirkegaard, 2003). YFV-17D plaque assays were per-
formed as described using 106 BHK cells seeded into wells of 6-
well plates. Monolayers were stained with crystal violet at 5 d
post-infection (Erickson and Pfeiffer, 2013). For co-infection
experiments with poliovirus and reovirus (Fig. 6), we could dis-
criminate reovirus plaques from poliovirus plaques because L929
cells do not support poliovirus replication due to the absence
of PVR.
Reoviruses harboring the nine different mutated M1 genome
segments were recovered by plasmid-based rescue (Kobayashi
et al., 2010). Monolayers of BHK-T7 cells at 90% conﬂuency (3
106 cells) seeded in 60-mm dishes (Costar; Corning Inc., Corning,
NY) were co-transfected with 10 plasmids representing the cloned
reovirus T3D genome using 3 μL of TransIT-LT1 transfection
reagent (Mirus Bio LLC; Madison, WI) per μg of plasmid DNA.
Following 72 h of incubation, recombinant viruses were isolated
from transfected cells by plaque puriﬁcation using monolayers of
L929 cells. (Virgin et al., 1988). High-titer reovirus stocks were
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chloride gradient centrifugation (Furlong et al., 1988).
The relative ﬁtness of the nine genetically marked reoviruses
was evaluated by a serial passage competition experiment
(Erickson and Pfeiffer, 2013; Kuss et al., 2008). Each of the nine
viruses at a dose of 106 PFU was mixed together and adsorbed to
106 L929 cells. After 24 h of incubation, infected cells were col-
lected, and 25% of the harvested cells were plated on a fresh
monolayer of 106 L929 cells to initiate further replication cycles.
This process was repeated for a total of 7 passages, and the relative
ratios of each virus in each passage were quantiﬁed by hybridi-
zation assay as described below. Pool member ﬁtness was assessed
in vivo by calculating the number of times each pool member was
detected relative to the total possible number of times that the
pool member could have been detected. Pool member totals were
from all reovirus mouse experiments, with the exception of any
experiments where all nine pool members were detected in all
possible tissues.
Mouse experiments
All animals were handled in strict accordance with good animal
practice as deﬁned by the Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health. All mouse studies
were performed at the University of Texas Southwestern Medical
Center (Animal Welfare Assurance no. A3472-01) using protocols
approved by the UT Southwestern Institutional Animal Care and
Use Committee (IACUC). All studies were performed in a manner
designed to minimize pain and suffering, and any animals that
exhibited severe disease signs were euthanized immediately in
accordance with IACUC-approved endpoints. C57BL/6 hPVR-Tg21
mice (called IFNARþ/þ throughout) and C57BL/6 hPVR-Tg21 mice
lacking the IFN-α/β receptor (called IFNAR/ throughout) were
provided by Koike (Tokyo, Japan) (Ida-Hosonuma et al., 2005;
Koike et al., 1991a). Although PVR expression is required only for
poliovirus infection, we used the PVR-transgenic mice for all
viruses in this study to allow direct comparisons to be made using
isogenic strains. We mixed equal PFU of each pool member for a
total of 107 PFU/mouse in 30 μL for 6-10 week-old adult mice or
10 μL for 3-day-old mice and inoculated the mixture into the
lower left gastrocnemius muscle (Kuss et al., 2008). For YFV-17D
infection of 3-day-old mice, the inoculum was 104 PFU due to low
virus concentration and the small 10 μL inoculum. Muscle damage
was induced in adult mice by inserting a 29-gauge needle 5 times
once daily into the muscle around the inoculation site (Fig. 1).
Muscle damage was not induced in 3-day old mice due to their
small size. Mice were euthanized at a predetermined endpoint or
at the onset of disease signs, whichever occurred earliest,
according to IACUC-approved methods.
Tissue harvest, processing and viral diversity assays
Several tissues (muscle, sciatic nerve, spinal cord, brain, blood)
were collected as described (Erickson and Pfeiffer, 2013; Lancaster
and Pfeiffer, 2010). Adult mice infected with YFV-17D were per-
fused with PBS prior to tissue collection due to moderate viral
titers in blood. Perfusion was not performed in poliovirus- or
reovirus-infected mice due to negligible viral titers in blood. In
experiments using adult mice, the sciatic nerve was sectioned into
lower, middle, and upper segments (Lancaster and Pfeiffer, 2010).
The upper sciatic nerve segment included both the dorsal root
ganglia and the motor nerves. The spinal cord was collected as the
whole spine from the lumbar vertebrae (L5–L6) to the middle of
the cervical vertebrae (C4–C5). Tissues were weighed and sus-
pended in 1–3 volumes of PBS and homogenized with a Bullet
Blender (Next Advance, Inc, Averill Park, NY) according to themanufacturer's instructions. Tissues from YFV-17D or reovirus-
infected mice were frozen and thawed once prior to homo-
genization, whereas poliovirus-infected tissues were frozen and
thawed three times after homogenization. All samples were cen-
trifuged at 13,000 rpm for 1 min to isolate virus-containing
supernatant. Virus titers in supernatants were quantiﬁed by pla-
que assay and ampliﬁed prior to the viral population diversity
assay to aid in detection of pool members. Poliovirus was ampli-
ﬁed in HeLa cells until cytopathic effects were apparent (6–48 h,
depending on the tissue). YFV-17D was ampliﬁed for 48 h in BHK
cells (Erickson and Pfeiffer, 2013). Reovirus was ampliﬁed follow-
ing a 1:10 dilution of supernatant and plated on L929 cells. Cells
were incubated at 37 °C for 12 h to 5 d, depending upon tissue
titer, and monitored regularly for cytopathic effects. In all cases,
cells were collected in 1 mL TRI reagent, and RNA was extracted as
described (Kuss et al., 2008; Lancaster and Pfeiffer, 2010). RT-PCR
of poliovirus and YFV-17D samples was performed as described
(Erickson and Pfeiffer, 2013; Kuss et al., 2008). RT-PCR of reovirus
samples was performed as described (Kuss et al., 2008; Pfeiffer
and Kirkegaard, 2005) with a few modiﬁcations to facilitate
ampliﬁcation of reovirus dsRNA. Total cellular RNA, the REO M1
614 antisense primer 50 TAGAGTGAGGAACACGACC 30, and all
reaction components except for SSII reverse transcriptase were
incubated at 100 °C for 20 min to separate dsRNA, allowed to cool
slowly to 42 °C, and then incubated with SSII reverse transcriptase
at 42 °C for 1 h. PCR reactions were performed as described
(Kuss et al., 2008), but with the M1 297 sense primer
50CGGACAACGTTGATCGTCG30 and the M1 542 antisense primer
50CGCATAGTACTTTCTAGGAGC30. Blotting and hybridization were
performed as described (Kuss et al., 2008) but with reovirus-
speciﬁc probes. The reovirus probe sequences are the reverse
complement of sequences shown in Fig. 4A, but with an extra T on
the 50 end of each. Reovirus probes were radiolabeled using T4
polynucleotide kinase and [γ-32P] ATP, and excess nucleotides
were removed with the Qiagen Nucleotide Removal Kit (Qiagen,
Valencia, CA). Hybridization was performed at 56 °C overnight,
followed by washing. Membranes were exposed to a Phosphor
Screen for 2 d and scanned with a STORM Scanner. Signals were
normalized to a mismatched control sample on each membrane as
described (Kuss et al., 2008).Acknowledgments
We thank Satoshi Koike for the PVR-transgenic mice and
Charlie Rice for the YFV-17D infectious clone. This work was
supported by U.S. Public Health Service awards AI074668 (J.K.P)
and AI038296 (T.S.D.) from the National Institute of Allergy and
Infectious Diseases and a Burroughs Wellcome Foundation Inves-
tigators in the Pathogenesis of Infectious Diseases award (J.K.P.).
Additional support was provided by the Elizabeth B. Lamb Center
for Pediatric Research. The funders had no role in study design,
data collection and analysis, decision to publish, or preparation of
the manuscript.References
Anderson, G.W., Skaar, A.E., 1951. Poliomyelitis occurring after antigen injections.
Pediatrics 7, 741–759.
Antar, A.A., Konopka, J.L., Campbell, J.A., Henry, R.A., Perdigoto, A.L., Carter, B.D.,
Pozzi, A., Abel, T.W., Dermody, T.S., 2009. Junctional adhesion molecule-A is
required for hematogenous dissemination of reovirus. Cell Host Microbe 5,
59–71.
Barton, E.S., Connolly, J.L., Forrest, J.C., Chappell, J.D., Dermody, T.S., 2001a. Utili-
zation of sialic acid as a coreceptor enhances reovirus attachment by multistep
adhesion strengthening. J. Biol. Chem. 276, 2200–2211.
L.N. Luethy et al. / Virology 487 (2016) 1–1010Barton, E.S., Forrest, J.C., Connolly, J.L., Chappell, J.D., Liu, Y., Schnell, F.J., Nusrat, A.,
Parkos, C.A., Dermody, T.S., 2001b. Junction adhesion molecule is a receptor for
reovirus. Cell 104, 441–451.
Barton, E.S., Youree, B.E., Ebert, D.H., Forrest, J.C., Connolly, J.L., Valyi-Nagy, T.,
Washington, K., Wetzel, J.D., Dermody, T.S., 2003. Utilization of sialic acid as a
coreceptor is required for reovirus-induced biliary disease. J. Clin. Investig. 111,
1823–1833.
Boehme, K.W., Frierson, J.M., Konopka, J.L., Kobayashi, T., Dermody, T.S., 2011. The
reovirus sigma1s protein is a determinant of hematogenous but not neural
virus dissemination in mice. J. Virol. 85, 11781–11790.
Campbell, J.A., Schelling, P., Wetzel, J.D., Johnson, E.M., Forrest, J.C., Wilson, G.A.,
Aurrand-Lions, M., Imhof, B.A., Stehle, T., Dermody, T.S., 2005. Junctional
adhesion molecule a serves as a receptor for prototype and ﬁeld-isolate strains
of mammalian reovirus. J. Virol. 79, 7967–7978.
Crotty, S., Hix, L., Sigal, L.J., Andino, R., 2002. Poliovirus pathogenesis in a new
poliovirus receptor transgenic mouse model: age-dependent paralysis and a
mucosal route of infection. J. Gen. Virol. 83, 1707–1720.
Dionne, K.R., Galvin, J.M., Schittone, S.A., Clarke, P., Tyler, K.L., 2011. Type I inter-
feron signaling limits reoviral tropism within the brain and prevents lethal
systemic infection. J. Neurovirol. 17, 314–326.
Erickson, A.K., Pfeiffer, J.K., 2013. Dynamic viral dissemination in mice infected with
yellow fever virus strain 17D. J. Virol. 87, 12392–12397.
Fitzgeorge, R., Bradish, C.J., 1980. The in vivo differentiation of strains of yellow
fever virus in mice. J. Gen. Virol. 46, 1–13.
Forrest, J.C., Campbell, J.A., Schelling, P., Stehle, T., Dermody, T.S., 2003. Structure-
function analysis of reovirus binding to junctional adhesion molecule 1.
Implications for the mechanism of reovirus attachment. J. Biol. Chem. 278,
48434–48444.
Frierson, J.M., Pruijssers, A.J., Konopka, J.L., Reiter, D.M., Abel, T.W., Stehle, T.,
Dermody, T.S., 2012. Utilization of sialylated glycans as coreceptors enhances
the neurovirulence of serotype 3 reovirus. J. Virol. 86, 13164–13173.
Furlong, D.B., Nibert, M.L., Fields, B.N., 1988. Sigma 1 protein of mammalian reo-
viruses extends from the surfaces of viral particles. J. Virol. 62, 246–256.
Gromeier, M., Wimmer, E., 1998. Mechanism of injury-provoked poliomyelitis. J.
Virol. 72, 5056–5060.
Guyer, B., Bisong, A.A., Gould, J., Brigaud, M., Aymard, M., 1980. Injections and
paralytic poliomyelitis in tropical Africa. Bull. World Heal. Organ. 58, 285–291.
Hill, A.B., Knowelden, J., 1950. Inoculation and poliomyelitis; a statistical investi-
gation in England and Wales in 1949. Br. Med. J. 2, 1–6.
Ida-Hosonuma, M., Iwasaki, T., Yoshikawa, T., Nagata, N., Sato, Y., Sata, T., Yoneyama,
M., Fujita, T., Taya, C., Yonekawa, H., Koike, S., 2005. The alpha/beta interferon
response controls tissue tropism and pathogenicity of poliovirus. J. Virol. 79,
4460–4469.
Kobayashi, T., Ooms, L.S., Ikizler, M., Chappell, J.D., Dermody, T.S., 2010. An
improved reverse genetics system for mammalian orthoreoviruses. Virology
398, 194–200.
Koike, S., Ise, I., Nomoto, A., 1991a. Functional domains of the poliovirus receptor.
Proc. Natl. Acad. Sci. USA 88, 4104–4108.
Koike, S., Taya, C., Kurata, T., Abe, S., Ise, I., Yonekawa, H., Nomoto, A., 1991b.
Transgenic mice susceptible to poliovirus. Proc. Natl. Acad. Sci. USA 88,
951–955.
Konopka-Anstadt, J.L., Mainou, B.A., Sutherland, D.M., Sekine, Y., Strittmatter, S.M.,
Dermody, T.S., 2014. The Nogo receptor NgR1 mediates infection by mamma-
lian reovirus. Cell Host Microbe 15, 681–691.
Koyuncu, O.O., Hogue, I.B., Enquist, L.W., 2013. Virus infections in the nervous
system. Cell Host Microbe 13, 379–393.
Kuss, S.K., Etheredge, C.A., Pfeiffer, J.K., 2008. Multiple host barriers restrict polio-
virus trafﬁcking in mice. PLoS Pathog. 4, e1000082.
Lancaster, K.Z., Pfeiffer, J.K., 2010. Limited trafﬁcking of a neurotropic virus through
inefﬁcient retrograde axonal transport and the type I interferon response. PLoS
Pathog. 6, e1000791.
Lee, E., Lobigs, M., 2008. E protein domain III determinants of yellow fever virus 17D
vaccine strain enhance binding to glycosaminoglycans, impede virus spread,
and attenuate virulence. J. Virol. 82, 6024–6033.
Maginnis, M.S., Forrest, J.C., Kopecky-Bromberg, S.A., Dickeson, S.K., Santoro, S.A.,
Zutter, M.M., Nemerow, G.R., Bergelson, J.M., Dermody, T.S., 2006. Beta1
integrin mediates internalization of mammalian reovirus. J. Virol. 80,
2760–2770.
Mainou, B.A., Zamora, P.F., Ashbrook, A.W., Dorset, D.C., Kim, K.S., Dermody, T.S.,
2013. Reovirus cell entry requires functional microtubules. mBio 4, e00405–13.
Mann, M.A., Knipe, D.M., Fischbach, G.D., Fields, B.N., 2002. Type 3 reovirus neu-
roinvasion after intramuscular inoculation: direct invasion of nerve terminals
and age-dependent pathogenesis. Virology 303, 222–231.
McCloskey, B.P., Melb, M.B., 1950. The relation of prophylactic inoculations to the
onset of poliomyelitis. Lancet 255, 659–663.
Meier, K.C., Gardner, C.L., Khoretonenko, M.V., Klimstra, W.B., Ryman, K.D., 2009. A
mouse model for studying viscerotropic disease caused by yellow fever virus
infection. PLoS Pathog. 5, e1000614.Mims, C.A., 1957. The invasion of the brain by yellow fever virus present in the
blood of mice. British. J. Exp. Pathol. 38, 329–338.
Monath, T.P., Barrett, A.D., 2003. Pathogenesis and pathophysiology of yellow fever.
Adv. Virus Res. 60, 343–395.
Morrison, L.A., Sidman, R.L., Fields, B.N., 1991. Direct spread of reovirus from the
intestinal lumen to the central nervous system through vagal autonomic nerve
ﬁbers. Proc. Natl. Acad. Sci. USA 88, 3852–3856.
Mueller, S., Cao, X., Welker, R., Wimmer, E., 2002. Interaction of the poliovirus
receptor CD155 with the dynein light chain Tctex-1 and its implication for
poliovirus pathogenesis. J. Biol. Chem. 277, 7897–7904.
Ohka, S., Igarashi, H., Nagata, N., Sakai, M., Koike, S., Nochi, T., Kiyono, H., Nomoto,
A., 2007. Establishment of a poliovirus oral infection system in human polio-
virus receptor-expressing transgenic mice that are deﬁcient in alpha/beta
interferon receptor. J. Virol. 81, 7902–7912.
Ohka, S., Matsuda, N., Tohyama, K., Oda, T., Morikawa, M., Kuge, S., Nomoto, A.,
2004. Receptor (CD155)-dependent endocytosis of poliovirus and retrograde
axonal transport of the endosome. J. Virol. 78, 7186–7198.
Ohka, S., Yang, W.X., Terada, E., Iwasaki, K., Nomoto, A., 1998. Retrograde transport
of intact poliovirus through the axon via the fast transport system. Virology
250, 67–75.
Pfeiffer, J.K., 2010. Innate host barriers to viral trafﬁcking and population diversity:
lessons learned from poliovirus. Adv. Virus Res. 77, 85–118.
Pfeiffer, J.K., Kirkegaard, K., 2003. A single mutation in poliovirus RNA-dependent
RNA polymerase confers resistance to mutagenic nucleotide analogs via
increased ﬁdelity. Proc. Natl. Acad. Sci. USA 100, 7289–7294.
Pfeiffer, J.K., Kirkegaard, K., 2005. Increased ﬁdelity reduces poliovirus ﬁtness and
virulence under selective pressure in mice. PLoS Pathog. 1, e11.
Pfeiffer, J.K., Kirkegaard, K., 2006. Bottleneck-mediated quasispecies restriction
during spread of an RNA virus from inoculation site to brain. Proc. Natl. Acad.
Sci. USA 103, 5520–5525.
Reiss, K., Stencel, J.E., Liu, Y., Blaum, B.S., Reiter, D.M., Feizi, T., Dermody, T.S., Stehle,
T., 2012. The GM2 glycan serves as a functional coreceptor for serotype 1 reo-
virus. PLoS Pathog. 8, e1003078.
Ren, R., Racaniello, V.R., 1992. Poliovirus spreads from muscle to the central ner-
vous system by neural pathways. J. Infect. Dis. 166, 747–752.
Saha, N., Kolev, M., Nikolov, D.B., 2014. Structural features of the Nogo receptor
signaling complexes at the neuron/myelin interface. Neurosci. Res. 87, 1–7.
Sawyer, W.A., Lloyd, W., 1931. The use of mice in tests of immunity against yellow
fever. J. Exp. Med. 54, 533–555.
Sherry, B., Torres, J., Blum, M.A., 1998. Reovirus induction of and sensitivity to beta
interferon in cardiac myocyte cultures correlate with induction of myocarditis
and are determined by viral core proteins. J. Virol. 72, 1314–1323.
Strebel, P.M., Ion-Nedelcu, N., Baughman, A.L., Sutter, R.W., Cochi, S.L., 1995.
Intramuscular injections within 30 days of immunization with oral poliovirus
vaccine – a risk factor for vaccine-associated paralytic poliomyelitis. N. Engl. J.
Med. 332, 500–506.
Tardieu, M., Powers, M.L., Weiner, H.L., 1983. Age dependent susceptibility to reo-
virus type 3 encephalitis: role of viral and host factors. Ann. Neurol. 13,
602–607.
Theiler, M., 1930. Susceptibility of white mice to the virus of yellow fever. Science
71, 367.
Thibodeaux, B.A., Garbino, N.C., Liss, N.M., Piper, J., Blair, C.D., Roehrig, J.T., 2012. A
small animal peripheral challenge model of yellow fever using interferon-
receptor deﬁcient mice and the 17D-204 vaccine strain. Vaccine 30, 3180–3187.
Tyler, K.L., McPhee, D.A., Fields, B.N., 1986. Distinct pathways of viral spread in the
host determined by reovirus S1 gene segment. Science 233, 770–774.
Vignuzzi, M., Stone, J.K., Arnold, J.J., Cameron, C.E., Andino, R., 2006. Quasispecies
diversity determines pathogenesis through cooperative interactions in a viral
population. Nature 439, 344–348.
Virgin, H.Wt, Bassel-Duby, R., Fields, B.N., Tyler, K.L., 1988. Antibody protects
against lethal infection with the neurally spreading reovirus type 3 (Dearing). J.
Virol. 62, 4594–4604.
Weiner, H.L., Drayna, D., Averill Jr., D.R., Fields, B.N., 1977. Molecular basis of reo-
virus virulence: role of the S1 gene. Proc. Natl. Acad. Sci. USA 74, 5744–5748.
Weiner, H.L., Powers, M.L., Fields, B.N., 1980. Absolute linkage of virulence and
central nervous system cell tropism of reoviruses to viral hemagglutinin. J.
Infect. Dis. 141, 609–616.
Wyatt, H.V., 1985. Provocation of poliomyelitis by multiple injections. Trans. R. Soc.
Trop. Med. Hyg. 79, 355–358.
Yang, W.X., Terasaki, T., Shiroki, K., Ohka, S., Aoki, J., Tanabe, S., Nomura, T., Terada,
E., Sugiyama, Y., Nomoto, A., 1997. Efﬁcient delivery of circulating poliovirus to
the central nervous system independently of poliovirus receptor. Virology 229,
421–428.
